Quick Answer
Catheter Precision, Inc. reported Stockholders Equity of $7.05 million for the year ending 2025.
- Catheter Precision, Inc. showed a decrease of -40.0% in Stockholders Equity from 2024 to 2025.
- This data is from Catheter Precision, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: -$8.91 million | Q2 2018: $9.78 million | Q3 2018: $6.48 million | Q1 2019: $59.80 million | Q2 2019: $51.90 million | Q3 2019: $41.74 million | Q1 2020: $26.47 million | Q2 2020: $26.98 million | Q3 2020: $30.54 million | Q1 2021: $15.15 million | Q2 2021: $21.26 million | Q3 2021: $21.55 million | Q1 2022: $18.11 million | Q2 2022: $9.79 million | Q3 2022: $12.51 million | Q1 2023: $35.86 million | Q2 2023: $23.79 million | Q3 2023: $21.87 million | Q4 2023: $21.19 million | Q1 2024: $18.52 million | Q2 2024: $14.32 million | Q3 2024: $12.83 million | Q1 2025: $7.92 million | Q2 2025: $6.79 million | Q3 2025: $6.78 million.
- Over the full 10 years of available data (2016 to 2025), Catheter Precision, Inc.'s Stockholders Equity has grown by 1,956.3%.
- Historical annual values: Fiscal year 2025: $7.05 million | Fiscal year 2024: $11.76 million | Fiscal year 2023: $21.19 million | Fiscal year 2022: $9.26 million | Fiscal year 2021: $13.67 million | Fiscal year 2020: $21.15 million | Fiscal year 2019: $33.15 million | Fiscal year 2018: $66.73 million | Fiscal year 2017: -$7.62 million | Fiscal year 2016: -$380.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: